News
INTRATOMICS and UK’s Paragraf sign MoU to pioneer next-generation Graphene-Based Sensor Technologies
Khalifa University of Science and Technology today announced that INTRATOMICS Advanced Material Technologies (INTRATOMICS), a subsidiary of Khalifa University Enterprises Company (KUEC), has signed a memorandum of understanding (MoU) with Paragraf, the UK-based company pioneering the commercialization of graphene-based electronics using standard semiconductor processes, to jointly develop advanced graphene-enabled sensor
Read More
PlanetiQ wins $24.3M NOAA contract, largest commercial satellite weather data award ever
PlanetiQ, a leading provider of commercial weather and space weather data, has been awarded a $24.3 million contract from NOAA’s National Environmental Satellite, Data, and Information Service (NESDIS). The award, issued under the Commercial Data Program’s Radio Occultation Data Buy 2 (RODB-2), is NOAA’s single largest commercial satellite weather data
Read MoreParagraf closes $55M Series C funding round
Paragraf, the UK-based company leading the way in mass-producing graphene-based electronics using industry-standard semiconductor processes, has completed a $55m Series C funding round. The funding will accelerate scaling of Paragraf’s manufacturing capabilities and boost production output to enable the adoption of graphene electronics in mass markets. Paragraf’s technology integrates seamlessly
Read More
Ferric launches new Integrated Voltage Regulator for AI and high-performance processors
Ferric, the leader in cutting-edge power conversion solutions, has announced the launch of its latest flagship product, Fe1766, an Integrated Voltage Regulator (IVR) that sets new standards in current delivery, power density, efficiency, and regulation bandwidth for the most power-hungry digital processors. Built to address power demands of AI processors,
Read More
VORAGO introduces VA5 family of Dual-Core Rad-Hard and Rad-Tolerant Microcontrollers for next-gen space and defense systems
VORAGO Technologies, a leader in radiation-hardened and extreme-temperature semiconductor solutions, has announced the upcoming availability of the VA5 family, a new generation of dual-core Arm® Cortex®-M55 microcontrollers engineered to meet the rigorous demands of aerospace, defense, and deep space missions. The family includes both radiation-hardened and radiation-tolerant variants—providing engineers the
Read More
Richardson Electronics, Ltd. strengthens power management portfolio with Pakal Technologies Global Technology Partner Agreement
Richardson Electronics, Ltd. (NASDAQ: RELL) has announced a global technology partner agreement with Pakal Technologies, Inc., a cutting-edge innovator in silicon power semiconductor solutions. Under this agreement, Richardson Electronics will partner with Pakal to supply customers with Pakal’s advanced 650V and 1200V silicon-based power switches—delivering breakthrough efficiency to customers worldwide. Pakal
Read More
Novadip and Cliniques universitaires Saint-Luc report positive results for compassionate use of NVD003 on four pediatric patients
Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, and the Cliniques universitaires Saint-Luc have announced the successful treatment of four pediatric patients with Congenital Pseudarthrosis of the Tibia (CPT) using NVD003, an autologous therapy developed by Novadip for the reconstruction of bone tissue. CPT is a very
Read MoreNovadip receives RMAT designation for NVD003, its regenerative treatment for congenital pseudarthosis of the tibia
Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to its tissue regeneration product, NVD003, for the treatment of congenital pseudarthosis of the tibia (CPT). The RMAT designation, issued to cell therapies, therapeutic tissue
Read More
Ventyx Biosciences announces positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in patients with early-stage Parkinson’s disease
Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, the “Company”), a clinical-stage biotech company developing oral therapies for autoimmune, inflammatory and neurodegenerative diseases, has announced positive top-line results from its Phase 2a study of VTX3232, a novel, CNS-penetrant NLRP3 inhibitor, in patients with early-stage Parkinson’s disease (NCT06556173). The study accomplished the primary
Read More
Resolve Therapeutics and Duke Medical School initiate observational study of cell-free RNA in polytrauma patients
Resolve Therapeutics, a leader in the emerging field of cell-free nucleic acid therapeutics, has announced a collaboration with the Department of Surgery, Duke University School of Medicine to analyze the role of cell-free RNA (cfRNA) in polytrauma. A significant number of trauma patients admitted to the hospital each year suffer
Read More
Achronix announces new VectorPath 815 FPGA Accelerator Card
Achronix Semiconductor Corporation, the leader in data acceleration FPGAs, has announced the launch of the VectorPath® 815 (VP815), a new PCIe accelerator card powered by the industry- leading Speedster® 7t1500 FPGA, and engineered to meet the growing demands of AI workloads and high-performance computing (HPC). FPGAs are uniquely suited for
Read MoreNovadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
Novadip Biosciences, a late-stage clinical biotechnology company specializing in regenerative medicine, has announced the five-year follow-up results from the Phase 1/2 clinical trial of its investigational tissue regeneration product, NVD003, in adult patients with severe bone non-union (BNU) of the lower limb, following trauma. The five-year safety and efficacy data
Read More